background: More than half of recurrent pregnancy loss (RPL) remains unexplained. We hypothesized that women with a history of unexplained RPL (URPL) have low venous reserve.
Introduction
First trimester pregnancy loss affects up to 15% of clinically recognized pregnancies (Rai and Regan, 2006) . Whereas most couples have successful subsequent pregnancies, 3% of the couples trying to conceive suffer from recurrent pregnancy loss (RPL) (Rai and Regan, 2006; Jaslow et al., 2010) . The American Society for Reproductive Medicine (2008) redefined RPL in 2008 as two or more failed clinical pregnancies as documented by ultrasonography or histopathologic examination. Underlying conditions known to relate to RPL are anatomical uterine abnormalities, endocrine disorders, thrombophilia and chromosomal disorders. Nonetheless, even after extensive screening for these associated disorders, about half of RPL remains unexplained. This suggests that other, currently unknown, underlying factors are involved in RPL. Absence of an explanation for the recurrence contributes to depression and anxiety in women with RPL (Craig et al., 2002) .
In women with RPL, the non-pregnant pulsatility index (PI) and the impedance in the uterine arteries are increased (Habara et al., 2002; Ferreira et al., 2007; Sikora et al., 2007) . This pre-pregnancy circulatory profile reflects a high resistance to uterine flow. Women with a history of a pregnancy complicated by pre-eclampsia have comparable pre-pregnancy circulatory profile. In these formerly preeclamptic women, the non-pregnant PI in the uterine arteries inversely correlates with venous compliance which, in turn, correlates with plasma volume (PV) . Along with venous compliance, PV represents the cardiovascular or, more specifically, the venous reserve capacity (Krabbendam et al., 2008b) . Venous reserve capacity represents the ability of the venous system to adapt to arterial demands. A mismatch between venous reserve capacity and arterial demands is known to correlate with adverse pregnancy outcomes, like fetal growth restriction . Women diagnosed with RPL have a higher risk of vascularcomplicated pregnancies in the next ongoing pregnancy (Weintraub et al., 2005; Trogstad et al., 2008; Trogstad et al., 2009 ). These findings suggest a common risk profile between women with RPL and women prone to develop pre-eclampsia or fetal growth restriction.
Based on these observations, we hypothesized that women with unexplained RPL (URPL) may have low pre-pregnancy venous reserve capacity, characterized by low PV and low venous compliance.
Materials and methods
We conducted an exploratory observational case -control study in 35 women. We compared 12 women with unexplained, not necessarily consecutive, RPL with two separate control groups. The first control group consisted of 11 healthy nulliparous women and the second control group included 12 healthy primiparous women, with a history of uncomplicated pregnancy. Women were matched for age and body mass index (BMI). Patients were recruited from the outpatient department of Obstetrics and Gynecology, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands; controls were recruited by advertisement. URPL was defined as two or more pregnancy losses, clinically confirmed by either ultrasound or histopathology, at a gestational age of ,20 weeks, without an underlying diagnosis after standard evaluation according to Dutch national guidelines (www.nvog.nl). Standard evaluation after RPL consisted of thrombophilia screening, parental karyotypic evaluation, endocrine screening and ultrasonographic examination for possible uterine anomalies. The standard thrombophilia screening after RPL consisted of evaluation of Factor V Leiden (F5 R506Q mutation), Factor II (G20210A mutation), Protein S deficiency (in duplicate: Total Protein S , 70% or Free Protein S , 65%), Protein C deficiency (in duplicate: Protein C activity ,70%) and hyperhomocysteinemia (fasting homocysteïne .12.1 mmol/l). Endocrine evaluation consisted of determining thyroid function (normal thyroid-stimulating hormone level: 0.4 mE/l till 4 mE/l) and fasting glucose levels (normal level ,6.1 mmol/l). Uterine anatomical defects were identified by 3D sonohysterography. Any condition resulting in the deformation of the uterine cavity was considered abnormal. Women with any thrombophilic, endocrine, karyotypic or anatomical abnormality were excluded from the study. Smokers and participants who reported any pre-existing chronic medical condition were also excluded. All participants were normally active (exercise 1 -3 days/ week for at least 1 h). In patients, all measurements were performed at least 4 -8 months after the last pregnancy loss. At the time of the measurements, none of the participants used medication and no hormonal contraceptives, and all primiparous women had discontinued breastfeeding. All primiparous women were studied at least 6 months postpartum to allow postpartum recovery of hemodynamic variables. The study procedures were approved by the institutional review board (CMO nr: 2009/004) and written informed consent was obtained from all participants.
All experiments were performed in the follicular phase of the menstrual cycle to minimize hormonal influences. Measurements were conducted between 8.00 and 11.00 a.m. after an overnight fast in a quiet, temperature controlled, environment of 23 + 18C. Participants were instructed to avoid moderate and strenuous exercise in the 24 h preceding the experiment. All measurements were performed by one experienced physician (R.S.) using the same technical devices during each measurement.
Height and body mass (Seca 888 scale, Hamburg, Germany) were measured. All hemodynamic variables were measured as previously described (Krabbendam et al., 2009) . Arterial blood pressure and heart rate were recorded at 3-min intervals using a semiautomatic oscillometric device (Dinamap Vital Signs Monitor 1846, Critikon Company LLC, Tampa, FL, USA). Measurements were done with the cuff size recommended for the arm circumference. The median value of five consecutive measurements was used. Pulse pressure (mmHg) was calculated as the difference between systolic and diastolic blood pressure. Cardiac output (CO, I/min) was measured in the left lateral position using a validated, non-invasive, inert gas rebreathing method (Innocor, Innovision, Copenhagen, Denmark) (Gabrielsen et al., 2002; Peyton and Thompson, 2004) . Cardiac index (CI) was calculated as CO/body surface area ((l/min)/ m 2 ). Venous compliance in forearm and calf (VC arm , VC calf , (ml/dl)/ mmHg) were determined from the plethysmographically derived slope of the relationship between venous volume and pressure change (Strain Gauge Plethysmograph, Hokanson, Bellevue, WA, USA). Participants were comfortably placed in the supine position. The right arm was placed at heart level with the arm extended and supported at an angle of 808 from the torso. The right leg was placed in such a way that the right medial malleolus was at heart level, with the leg extended in the direction of the body axis. Mercury-in-silastic strain gauges were placed around the largest girth of the right calf and forearm. A pressure cuff was placed around the upper right leg and arm and connected to a rapid cuff inflator (Stopler E-20, Hokanson, Bellevue, WA, USA) to ensure rapid and accurate filling and deflating of the cuff. Care was taken not to have exterior compression from the underlying surface on cuffs or gauges. After instrumentation, the strain gauges were calibrated electronically. The experimental procedures started after a supine resting period of at least 20 min. By protocol, we started with an occlusion pressure of 20 mmHg for at least 2 min and subsequent cuff pressures of 40, 60, and 80 mmHg were used for at least 3, 4 and 5 min, respectively, to achieve a stable plateau of the plethysmographic signal. The effective pressure on the venous system was estimated as 0.8 times the cuff pressure (Whitney, 1953) . Data were recorded at a sample frequency of 100 Hz (MIDAC, Instrumentation Department, Radboud University Nijmegen, The Netherlands) and analyzed by a customized computer program (Matlab, Mathworks, Natick, MA, USA.). The venous volume variation (VVV, ml/dl) was defined as the maximal relative volume increase in a limb at each chosen cuff pressure. The VVV at different (effective) cuff pressures represents the pressure -volume curve which was used to calculate the venous compliance (Krabbendam et al., 2009) . The reproducibility of measuring venous compliance by plethysmography was tested in our laboratory. Coefficient of variation varied between 16% and 20% (de Groot et al., 2005) . PV (ml/m 2 ) was measured using the 125 I-labeled albumin ( 125 I-HSA) indicator dilution method as described elsewhere (Spaanderman et al., 2000; Krabbendam et al., 2009) . Prior to the administration of the radioactive albumin, a venous blood sample was drawn to determine background activity as well as hemoglobin (mmol/l) and hematocrit (l/l) levels. Taking 150 ml/m 2 difference in PV as clinically significant (a ¼ 0.05, power 90%), based on previous finding of PV in healthy primiparous women, eight women are needed in each group (Scholten et al., 2011) . For forearm venous compliance, to find a 0.02 ml/dl/mmHg difference as clinically important, at a ¼ 0.05 and power 90%, based on previous findings, we needed to include 11 women in each group (Krabbendam et al., 2008a) . We chose to include at least 11 subjects for each subgroups. Statistical analysis was performed using Statistical Package for Social Sciences (SPSS) 16.0 (SPSS Inc., Chicago, IL, USA). All values are reported as means + SD unless otherwise stated. Differences between groups were tested using one-way analysis of variance along with Bonferroni correction to correct for multiple testing. Kendall rank correlation coefficients between PV and venous compliance were calculated for each subgroup (URPL and nulliparous and primiparous controls, respectively) to compare correlations between groups. Pearson correlation coefficients were calculated to estimate correlation between PV and venous compliance in forearm and between PV and venous compliance in calf. The level of statistical significance was set at a ¼ 0.05.
Results
We evaluated 12 women with URPL, 11 nulliparous controls and 12 primiparous controls between July 2009 and July 2010. Seven women had a history of two pregnancy losses, four women had three pregnancy losses and one woman had a history of four pregnancy losses at the time of evaluation. The median gestational age of ultrasound ascertainment or clinically evident pregnancy loss in patients was 10 weeks + 3 days (minimum: 7 weeks + 2 days; maximum: 16 weeks + 6 days). The mean interval between last pregnancy loss and cardiovascular evaluation was 27 + 3 weeks. In primiparous controls, the mean interval between delivery and cardiovascular evaluation was 33 + 4 weeks.
Subject characteristics did not differ between groups (Table I) . Hemodynamically, women who were diagnosed with URPL differed from both control groups by higher mean pulse pressure, lower PV and lower venous compliance in both forearm and calf, while mean cardiac indices did not differ between groups (Table II) . Pulse pressure was higher in women with URPL (50 + 7 mmHg) compared with both nulliparous (44 + 2 mmHg) and primiparous (43 + 5 mmHg) controls (P ¼ 0.03 and P ¼ 0.003), respectively. PV in women with URPL was 14% lower compared with nulliparous controls (1407 versus 1633 ml/m 2 , P , 0.01) and 9% lower compared with primiparous controls (1407 versus 1549 ml/m 2 , P ¼ 0.04). Mean PV did not differ between the two control groups (P ¼ 0.41). Venous compliance in the forearm (5.8 × 10 22 (ml/dl)/mmHg) was lower in women with URPL when compared with both nulliparous (7.6 × 10 22 (ml/dl)/ mmHg, P ¼ 0.04) and primiparous controls (8.5 × 10 22 (ml/dl)/ mmHg, P , 0.01). Calf venous compliance was also lower in women with URPL (7.4 × 10 22 (ml/dl)/mmHg) when compared with nulliparous (10.4 × 10 22 (ml/dl)/mmHg, P , 0.01) and primiparous controls (9.6 × 10 22 (ml/dl)/mmHg, P ¼ 0.03), respectively.
Mean venous compliance in both forearm and calf did not differ between the two control groups (P ¼ 0.72 and P ¼ 0.89, respectively). Kendall rank correlations between PV and forearm venous compliance in women with URPL were 0.38 (P ¼ 0.21) and 0.42 (P ¼ 0.07) in nulliparous controls and 0.42 (P ¼ 0.01) in primiparous controls, respectively. Kendall rank correlations between PV and calf venous compliance in women with URPL were 0.12 (P ¼ 0.64) and 0.13 (P ¼ 0.58) in nulliparous controls and 0.33 (P ¼ 0.05) in primiparous controls, respectively. Based on comparable correlation coefficients between subgroups, data were combined to calculate total correlation coefficients between PV and venous compliance. Total correlation coefficient (r) was 0.61 (P , 0.01) for the forearm and 0.52 (P , 0.01) for the calf (Fig. 1 ). All the individual data for PV and venous compliance are shown.
Discussion
The major finding in the present exploratory study is a lower venous reserve capacity in women with URPL when compared with controls.
At comparable arterial demands, as indicated by the CI, women who experienced URPL had lower mean PV and lower venous compliance in both forearm and calf when compared with both nulliparous and primiparous controls. When women are systematically evaluated for possible underlying conditions after RPL, in 40 -50% no etiologic factor is found. In an observational study of 1020 women with at least two pregnancy losses, an anatomical factor was found in 18%, a immunological factor in 17%, an endocrine factor in 8%, a thrombotic factor in 7% and a genetic factor in only 4% (Jaslow et al., 2010) . Although parental genetic abnormalities may increase with increasing pregnancy losses, others demonstrated that the prevalence of abnormal results do not increase for most other abnormalities among women with different numbers of pregnancy losses (two, three or more) (Franssen et al., 2005; Jaslow et al., 2010) .
Few studies have evaluated possible hemodynamic mechanisms in the pathophysiology of URPL. In these studies, the focus has always been on the arterial system. Previous studies demonstrated elevated uterine PI and flow wave velocity in women with URPL consistent with increased arterial stiffness (Habara et al., 2002; Ferreira et al., 2007) . In our study, women with URPL demonstrated higher mean pulse pressure. Since the mean stroke volumes were comparable, this suggests low arterial compliance, which is consistent with previous findings (Habara et al., 2002; Ferreira et al., 2007) . With mean hemoglobin levels of 7.6 + 0.4 mmol/l and no differences in hemoglobin levels between groups, severe anemia was excluded as an explanation for the increased arterial pulse pressure. Cardiac valve regurgitation is also an unlikely explanation in these young women. Loss of arterial compliance may also originate from increased sympathetic tone or reduced bioavailability of endothelium derived nitric oxide. Future studies are needed to elucidate these interactions.
Our study suggests a higher prevalence of reduced venous reserve capacity in women with URPL. In healthy persons, PV remains relatively constant as a result of tight regulation by the complex interaction between neurohormonal systems involved in sodium and water homeostasis (Kalra et al., 2002) . Important mechanisms involved in the PV regulation are the sodium-and water-retaining effects of the renin -angiotensin -aldosterone system (RAAS), the diuretic effects of natriuretic peptides in response to atrial and ventricular wall stretch, and actions of the sympathetic nervous system (Kalra et al., 2002) . The sympathetic system acts on PV through a range of effects on both the kidneys and vasculature (Kalra et al., 2002) ; the latter in particular by acting on the functional venous capacitance. With comparable kidney functions between groups, our study indicates that the lower PV status in women with URPL unlikely results from markedly impaired kidney function.
The consequences of low PV for a subsequent ongoing pregnancy are currently unknown. A recent study demonstrated that in formerly preeclamptic women, a low pre-pregnancy PV relates to preeclampsia and fetal growth restriction in the subsequent pregnancy (Scholten et al., 2011) . We speculate, in line with others (Burton and Jauniaux, 2004) , that low venous reserve relates to restricted uterine perfusion that affects the uterine environment to such an extent that it influences embryonic, placental and uterine spiral artery development and may induce clinical entities such as RPL, hypertensive pregnancy and fetal growth restriction.
Early pregnancy is characterized by many important hemodynamic changes. Initially, there is a drop in vascular resistance. The exact mechanism for this drop in resistance is unknown. The resultant decrease in cardiac after load reduces arterial blood pressure which is counteracted by a baroreceptor-mediated increase in CO and an increase in PV by RAAS activation (Duvekot et al., 1993; Duvekot and Peeters, 1994) . Physiologically, PV increases by 10-15% within the first 12 weeks of gestation (Lund and Donovan, 1967; Whittaker and Lind, 1993; Bernstein et al., 2001) . The resultant high flow, low resistance circulation of pregnancy is thought to be essential for healthy ongoing pregnancy. With further fetal development, adequate unstressed venous volume reserves are pivotal to meet the increasing uterine demands (Krabbendam et al., 2008b) . Women with reduced venous reserves are less capable to mobilize venous volume in response to increased arterial demands (e.g. pregnancy, Krabbendam et al., 2008b , or exercise, Aardenburg et al., 2005 , by which it can be insufficient for the fetus to develop. These women may need sustained increased sympathetic tone to meet the arterial demands of early pregnancy. Inadequate venous reserve capacity may then be detrimental and relate to both early and late pregnancy loss.
In contrast to many other factors associated with RPL, low venous reserve capacity is modifiable prior to a subsequent pregnancy. Aerobic exercise is known to induce PV expansion (Convertino, 1991; Sawka et al., 2000) . This effect is initially established mainly through activation of the RAAS resulting in sodium retention. If training is continued, PV is further expanded through de novo protein synthesis, increasing oncotic intravascular pressure, by lowering of the sympathetic tone (Mueller, 2007) and increasing venous compliance (Krabbendam et al., 2009) . In this line of reasoning, women with RPL might benefit from aerobic exercise training through improvement of their cardiovascular reserve capacity. This study population was modestly sized. We compared the hemodynamic profiles in women with URPL with nulliparous and primiparous control groups. The mean PVs of both control groups were similar and compare well with the PVs observed in a previous study in healthy women (Bernstein et al., 2003) . Observing no differences in hemodynamic parameters between nulliparous and primiparous controls strengthens the idea that the two groups are an adequate representation of healthy controls. Future studies have to elucidate the contribution and impact of hemodynamic abnormalities in women with URPL and the possible beneficial effects of interventions aimed at improving these hemodynamic profiles.
In summary, women with URPL demonstrate reduced venous reserves when compared with healthy nulliparous and primiparous controls. Reduced venous reserve capacity is a potentially modifiable factor in the pathophysiology of RPL. Future research is needed to clarify the clinical relevance of reduced venous reserve capacity in women who experienced RPL. Figure 1 Correlation between PV (ml/m 2 ) and venous compliance ((ml/dl)/mmHg) in forearm (a) and calf (b) in women with URPL (n ¼ 12) and healthy nulliparous (n ¼ 11) and primiparous controls with a history of uncomplicated pregnancy (n ¼ 12).
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